nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—kidney cancer	0.662	1	CbGaD
Dicyclomine—CHRM3—ureter—kidney cancer	0.0127	0.754	CbGeAlD
Dicyclomine—CHRM3—renal system—kidney cancer	0.00101	0.0599	CbGeAlD
Dicyclomine—CHRM3—kidney—kidney cancer	0.000977	0.0579	CbGeAlD
Dicyclomine—CYP1A1—renal system—kidney cancer	0.000757	0.0449	CbGeAlD
Dicyclomine—CYP1A1—kidney—kidney cancer	0.000732	0.0434	CbGeAlD
Dicyclomine—CYP1A1—cardiac atrium—kidney cancer	0.000678	0.0402	CbGeAlD
Dicyclomine—Asthenia—Everolimus—kidney cancer	0.000262	0.000816	CcSEcCtD
Dicyclomine—Pain—Sunitinib—kidney cancer	0.000261	0.000813	CcSEcCtD
Dicyclomine—Constipation—Sunitinib—kidney cancer	0.000261	0.000813	CcSEcCtD
Dicyclomine—Immune system disorder—Paclitaxel—kidney cancer	0.000261	0.000812	CcSEcCtD
Dicyclomine—Mediastinal disorder—Paclitaxel—kidney cancer	0.00026	0.00081	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Sorafenib—kidney cancer	0.00026	0.000808	CcSEcCtD
Dicyclomine—Hypertension—Gemcitabine—kidney cancer	0.000259	0.000807	CcSEcCtD
Dicyclomine—Pruritus—Everolimus—kidney cancer	0.000259	0.000805	CcSEcCtD
Dicyclomine—Anaphylactic shock—Vincristine—kidney cancer	0.000258	0.000804	CcSEcCtD
Dicyclomine—Oedema—Vincristine—kidney cancer	0.000258	0.000804	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—kidney cancer	0.000255	0.000794	CcSEcCtD
Dicyclomine—Nervous system disorder—Vincristine—kidney cancer	0.000253	0.000788	CcSEcCtD
Dicyclomine—Asthenia—Erlotinib—kidney cancer	0.000253	0.000788	CcSEcCtD
Dicyclomine—Mental disorder—Paclitaxel—kidney cancer	0.000253	0.000787	CcSEcCtD
Dicyclomine—Discomfort—Gemcitabine—kidney cancer	0.000253	0.000786	CcSEcCtD
Dicyclomine—Urticaria—Sorafenib—kidney cancer	0.000252	0.000785	CcSEcCtD
Dicyclomine—Erythema—Paclitaxel—kidney cancer	0.000251	0.000782	CcSEcCtD
Dicyclomine—Decreased appetite—Dactinomycin—kidney cancer	0.000251	0.000782	CcSEcCtD
Dicyclomine—Abdominal pain—Sorafenib—kidney cancer	0.000251	0.000781	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Sunitinib—kidney cancer	0.00025	0.000777	CcSEcCtD
Dicyclomine—Pruritus—Erlotinib—kidney cancer	0.00025	0.000777	CcSEcCtD
Dicyclomine—Fatigue—Dactinomycin—kidney cancer	0.000249	0.000776	CcSEcCtD
Dicyclomine—Pain—Dactinomycin—kidney cancer	0.000247	0.000769	CcSEcCtD
Dicyclomine—Tension—Paclitaxel—kidney cancer	0.000247	0.000768	CcSEcCtD
Dicyclomine—Anorexia—Vincristine—kidney cancer	0.000246	0.000766	CcSEcCtD
Dicyclomine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000245	0.000763	CcSEcCtD
Dicyclomine—Oedema—Gemcitabine—kidney cancer	0.000245	0.000763	CcSEcCtD
Dicyclomine—Nervousness—Paclitaxel—kidney cancer	0.000244	0.00076	CcSEcCtD
Dicyclomine—Dizziness—Vinblastine—kidney cancer	0.000243	0.000755	CcSEcCtD
Dicyclomine—Dizziness—Everolimus—kidney cancer	0.000242	0.000753	CcSEcCtD
Dicyclomine—Abdominal pain—Sunitinib—kidney cancer	0.000241	0.000751	CcSEcCtD
Dicyclomine—Nervous system disorder—Gemcitabine—kidney cancer	0.00024	0.000748	CcSEcCtD
Dicyclomine—Feeling abnormal—Dactinomycin—kidney cancer	0.000238	0.000742	CcSEcCtD
Dicyclomine—Vision blurred—Paclitaxel—kidney cancer	0.000237	0.000737	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000236	0.000736	CcSEcCtD
Dicyclomine—Hypoaesthesia—Capecitabine—kidney cancer	0.000236	0.000734	CcSEcCtD
Dicyclomine—Hypersensitivity—Sorafenib—kidney cancer	0.000234	0.000728	CcSEcCtD
Dicyclomine—Insomnia—Vincristine—kidney cancer	0.000234	0.000727	CcSEcCtD
Dicyclomine—Anorexia—Gemcitabine—kidney cancer	0.000234	0.000727	CcSEcCtD
Dicyclomine—Vomiting—Vinblastine—kidney cancer	0.000233	0.000726	CcSEcCtD
Dicyclomine—Dizziness—Erlotinib—kidney cancer	0.000233	0.000726	CcSEcCtD
Dicyclomine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000233	0.000726	CcSEcCtD
Dicyclomine—Vomiting—Everolimus—kidney cancer	0.000233	0.000724	CcSEcCtD
Dicyclomine—Paraesthesia—Vincristine—kidney cancer	0.000232	0.000722	CcSEcCtD
Dicyclomine—Agitation—Paclitaxel—kidney cancer	0.000231	0.000719	CcSEcCtD
Dicyclomine—Rash—Everolimus—kidney cancer	0.000231	0.000718	CcSEcCtD
Dicyclomine—Dermatitis—Everolimus—kidney cancer	0.00023	0.000717	CcSEcCtD
Dicyclomine—Headache—Vinblastine—kidney cancer	0.00023	0.000716	CcSEcCtD
Dicyclomine—Angioedema—Paclitaxel—kidney cancer	0.00023	0.000715	CcSEcCtD
Dicyclomine—Headache—Everolimus—kidney cancer	0.000229	0.000713	CcSEcCtD
Dicyclomine—Abdominal pain—Dactinomycin—kidney cancer	0.000229	0.000711	CcSEcCtD
Dicyclomine—Asthenia—Sorafenib—kidney cancer	0.000228	0.000709	CcSEcCtD
Dicyclomine—Malaise—Paclitaxel—kidney cancer	0.000227	0.000706	CcSEcCtD
Dicyclomine—Syncope—Paclitaxel—kidney cancer	0.000225	0.000702	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—kidney cancer	0.000225	0.000701	CcSEcCtD
Dicyclomine—Hypersensitivity—Sunitinib—kidney cancer	0.000225	0.0007	CcSEcCtD
Dicyclomine—Decreased appetite—Vincristine—kidney cancer	0.000225	0.000699	CcSEcCtD
Dicyclomine—Pruritus—Sorafenib—kidney cancer	0.000225	0.000699	CcSEcCtD
Dicyclomine—Vomiting—Erlotinib—kidney cancer	0.000224	0.000698	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000223	0.000694	CcSEcCtD
Dicyclomine—Fatigue—Vincristine—kidney cancer	0.000223	0.000693	CcSEcCtD
Dicyclomine—Rash—Erlotinib—kidney cancer	0.000222	0.000692	CcSEcCtD
Dicyclomine—Dermatitis—Erlotinib—kidney cancer	0.000222	0.000692	CcSEcCtD
Dicyclomine—Palpitations—Paclitaxel—kidney cancer	0.000222	0.000691	CcSEcCtD
Dicyclomine—Insomnia—Gemcitabine—kidney cancer	0.000222	0.00069	CcSEcCtD
Dicyclomine—Eye disorder—Capecitabine—kidney cancer	0.000222	0.000689	CcSEcCtD
Dicyclomine—Headache—Erlotinib—kidney cancer	0.000221	0.000688	CcSEcCtD
Dicyclomine—Loss of consciousness—Paclitaxel—kidney cancer	0.000221	0.000688	CcSEcCtD
Dicyclomine—Pain—Vincristine—kidney cancer	0.000221	0.000688	CcSEcCtD
Dicyclomine—Constipation—Vincristine—kidney cancer	0.000221	0.000688	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—kidney cancer	0.000221	0.000687	CcSEcCtD
Dicyclomine—Paraesthesia—Gemcitabine—kidney cancer	0.00022	0.000685	CcSEcCtD
Dicyclomine—Cardiac disorder—Capecitabine—kidney cancer	0.00022	0.000685	CcSEcCtD
Dicyclomine—Asthenia—Sunitinib—kidney cancer	0.000219	0.000682	CcSEcCtD
Dicyclomine—Dyspnoea—Gemcitabine—kidney cancer	0.000219	0.00068	CcSEcCtD
Dicyclomine—Nausea—Vinblastine—kidney cancer	0.000218	0.000679	CcSEcCtD
Dicyclomine—Somnolence—Gemcitabine—kidney cancer	0.000218	0.000678	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—kidney cancer	0.000217	0.000676	CcSEcCtD
Dicyclomine—Nausea—Everolimus—kidney cancer	0.000217	0.000676	CcSEcCtD
Dicyclomine—Hypertension—Paclitaxel—kidney cancer	0.000217	0.000676	CcSEcCtD
Dicyclomine—Pruritus—Sunitinib—kidney cancer	0.000216	0.000672	CcSEcCtD
Dicyclomine—Immune system disorder—Capecitabine—kidney cancer	0.000214	0.000666	CcSEcCtD
Dicyclomine—Mediastinal disorder—Capecitabine—kidney cancer	0.000214	0.000665	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—kidney cancer	0.000213	0.000663	CcSEcCtD
Dicyclomine—Decreased appetite—Gemcitabine—kidney cancer	0.000213	0.000663	CcSEcCtD
Dicyclomine—Hypersensitivity—Dactinomycin—kidney cancer	0.000213	0.000663	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000212	0.000658	CcSEcCtD
Dicyclomine—Discomfort—Paclitaxel—kidney cancer	0.000211	0.000658	CcSEcCtD
Dicyclomine—Fatigue—Gemcitabine—kidney cancer	0.000211	0.000658	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Vincristine—kidney cancer	0.000211	0.000657	CcSEcCtD
Dicyclomine—Dizziness—Sorafenib—kidney cancer	0.00021	0.000653	CcSEcCtD
Dicyclomine—Pain—Gemcitabine—kidney cancer	0.00021	0.000652	CcSEcCtD
Dicyclomine—Constipation—Gemcitabine—kidney cancer	0.00021	0.000652	CcSEcCtD
Dicyclomine—Nausea—Erlotinib—kidney cancer	0.00021	0.000652	CcSEcCtD
Dicyclomine—Dry mouth—Paclitaxel—kidney cancer	0.000209	0.000651	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—kidney cancer	0.000209	0.000651	CcSEcCtD
Dicyclomine—Mental disorder—Capecitabine—kidney cancer	0.000208	0.000646	CcSEcCtD
Dicyclomine—Asthenia—Dactinomycin—kidney cancer	0.000207	0.000646	CcSEcCtD
Dicyclomine—Confusional state—Paclitaxel—kidney cancer	0.000207	0.000644	CcSEcCtD
Dicyclomine—Erythema—Capecitabine—kidney cancer	0.000206	0.000642	CcSEcCtD
Dicyclomine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000205	0.000639	CcSEcCtD
Dicyclomine—Oedema—Paclitaxel—kidney cancer	0.000205	0.000639	CcSEcCtD
Dicyclomine—Abdominal pain—Vincristine—kidney cancer	0.000204	0.000636	CcSEcCtD
Dicyclomine—Dizziness—Sunitinib—kidney cancer	0.000202	0.000629	CcSEcCtD
Dicyclomine—Feeling abnormal—Gemcitabine—kidney cancer	0.000202	0.000628	CcSEcCtD
Dicyclomine—Shock—Paclitaxel—kidney cancer	0.000202	0.000628	CcSEcCtD
Dicyclomine—Vomiting—Sorafenib—kidney cancer	0.000202	0.000628	CcSEcCtD
Dicyclomine—Nervous system disorder—Paclitaxel—kidney cancer	0.000201	0.000626	CcSEcCtD
Dicyclomine—Tachycardia—Paclitaxel—kidney cancer	0.0002	0.000623	CcSEcCtD
Dicyclomine—Rash—Sorafenib—kidney cancer	0.0002	0.000623	CcSEcCtD
Dicyclomine—Dermatitis—Sorafenib—kidney cancer	0.0002	0.000622	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—kidney cancer	0.0002	0.000621	CcSEcCtD
Dicyclomine—Headache—Sorafenib—kidney cancer	0.000199	0.000619	CcSEcCtD
Dicyclomine—Anorexia—Paclitaxel—kidney cancer	0.000196	0.000609	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—kidney cancer	0.000195	0.000606	CcSEcCtD
Dicyclomine—Vision blurred—Capecitabine—kidney cancer	0.000194	0.000605	CcSEcCtD
Dicyclomine—Vomiting—Sunitinib—kidney cancer	0.000194	0.000604	CcSEcCtD
Dicyclomine—Rash—Sunitinib—kidney cancer	0.000193	0.000599	CcSEcCtD
Dicyclomine—Dermatitis—Sunitinib—kidney cancer	0.000192	0.000599	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—kidney cancer	0.000192	0.000598	CcSEcCtD
Dicyclomine—Ill-defined disorder—Capecitabine—kidney cancer	0.000191	0.000596	CcSEcCtD
Dicyclomine—Headache—Sunitinib—kidney cancer	0.000191	0.000595	CcSEcCtD
Dicyclomine—Hypersensitivity—Vincristine—kidney cancer	0.00019	0.000592	CcSEcCtD
Dicyclomine—Nausea—Sorafenib—kidney cancer	0.000189	0.000587	CcSEcCtD
Dicyclomine—Malaise—Capecitabine—kidney cancer	0.000186	0.000579	CcSEcCtD
Dicyclomine—Insomnia—Paclitaxel—kidney cancer	0.000186	0.000578	CcSEcCtD
Dicyclomine—Asthenia—Vincristine—kidney cancer	0.000185	0.000577	CcSEcCtD
Dicyclomine—Syncope—Capecitabine—kidney cancer	0.000185	0.000576	CcSEcCtD
Dicyclomine—Paraesthesia—Paclitaxel—kidney cancer	0.000184	0.000573	CcSEcCtD
Dicyclomine—Vomiting—Dactinomycin—kidney cancer	0.000184	0.000572	CcSEcCtD
Dicyclomine—Dyspnoea—Paclitaxel—kidney cancer	0.000183	0.000569	CcSEcCtD
Dicyclomine—Somnolence—Paclitaxel—kidney cancer	0.000182	0.000568	CcSEcCtD
Dicyclomine—Palpitations—Capecitabine—kidney cancer	0.000182	0.000567	CcSEcCtD
Dicyclomine—Rash—Dactinomycin—kidney cancer	0.000182	0.000567	CcSEcCtD
Dicyclomine—Nausea—Sunitinib—kidney cancer	0.000181	0.000565	CcSEcCtD
Dicyclomine—Loss of consciousness—Capecitabine—kidney cancer	0.000181	0.000564	CcSEcCtD
Dicyclomine—Dyspepsia—Paclitaxel—kidney cancer	0.000181	0.000562	CcSEcCtD
Dicyclomine—Decreased appetite—Paclitaxel—kidney cancer	0.000178	0.000555	CcSEcCtD
Dicyclomine—Hypertension—Capecitabine—kidney cancer	0.000178	0.000554	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000177	0.000551	CcSEcCtD
Dicyclomine—Fatigue—Paclitaxel—kidney cancer	0.000177	0.000551	CcSEcCtD
Dicyclomine—Asthenia—Gemcitabine—kidney cancer	0.000176	0.000547	CcSEcCtD
Dicyclomine—Constipation—Paclitaxel—kidney cancer	0.000175	0.000546	CcSEcCtD
Dicyclomine—Pain—Paclitaxel—kidney cancer	0.000175	0.000546	CcSEcCtD
Dicyclomine—Discomfort—Capecitabine—kidney cancer	0.000174	0.00054	CcSEcCtD
Dicyclomine—Pruritus—Gemcitabine—kidney cancer	0.000173	0.00054	CcSEcCtD
Dicyclomine—Dry mouth—Capecitabine—kidney cancer	0.000172	0.000535	CcSEcCtD
Dicyclomine—Nausea—Dactinomycin—kidney cancer	0.000172	0.000534	CcSEcCtD
Dicyclomine—Dizziness—Vincristine—kidney cancer	0.000171	0.000532	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—kidney cancer	0.00017	0.00053	CcSEcCtD
Dicyclomine—Confusional state—Capecitabine—kidney cancer	0.00017	0.000528	CcSEcCtD
Dicyclomine—Feeling abnormal—Paclitaxel—kidney cancer	0.000169	0.000526	CcSEcCtD
Dicyclomine—Oedema—Capecitabine—kidney cancer	0.000168	0.000524	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000168	0.000522	CcSEcCtD
Dicyclomine—Shock—Capecitabine—kidney cancer	0.000166	0.000516	CcSEcCtD
Dicyclomine—Nervous system disorder—Capecitabine—kidney cancer	0.000165	0.000514	CcSEcCtD
Dicyclomine—Tachycardia—Capecitabine—kidney cancer	0.000164	0.000511	CcSEcCtD
Dicyclomine—Vomiting—Vincristine—kidney cancer	0.000164	0.000511	CcSEcCtD
Dicyclomine—Urticaria—Paclitaxel—kidney cancer	0.000163	0.000507	CcSEcCtD
Dicyclomine—Rash—Vincristine—kidney cancer	0.000163	0.000507	CcSEcCtD
Dicyclomine—Dermatitis—Vincristine—kidney cancer	0.000163	0.000506	CcSEcCtD
Dicyclomine—Abdominal pain—Paclitaxel—kidney cancer	0.000162	0.000505	CcSEcCtD
Dicyclomine—Headache—Vincristine—kidney cancer	0.000162	0.000504	CcSEcCtD
Dicyclomine—Anorexia—Capecitabine—kidney cancer	0.000161	0.0005	CcSEcCtD
Dicyclomine—Vomiting—Gemcitabine—kidney cancer	0.000156	0.000485	CcSEcCtD
Dicyclomine—Rash—Gemcitabine—kidney cancer	0.000155	0.000481	CcSEcCtD
Dicyclomine—Dermatitis—Gemcitabine—kidney cancer	0.000154	0.00048	CcSEcCtD
Dicyclomine—Headache—Gemcitabine—kidney cancer	0.000154	0.000478	CcSEcCtD
Dicyclomine—Nausea—Vincristine—kidney cancer	0.000153	0.000478	CcSEcCtD
Dicyclomine—Insomnia—Capecitabine—kidney cancer	0.000152	0.000474	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000152	0.000473	CcSEcCtD
Dicyclomine—Paraesthesia—Capecitabine—kidney cancer	0.000151	0.000471	CcSEcCtD
Dicyclomine—Hypersensitivity—Paclitaxel—kidney cancer	0.000151	0.00047	CcSEcCtD
Dicyclomine—Dyspnoea—Capecitabine—kidney cancer	0.00015	0.000467	CcSEcCtD
Dicyclomine—Dyspepsia—Capecitabine—kidney cancer	0.000148	0.000461	CcSEcCtD
Dicyclomine—Asthenia—Paclitaxel—kidney cancer	0.000147	0.000458	CcSEcCtD
Dicyclomine—Decreased appetite—Capecitabine—kidney cancer	0.000146	0.000456	CcSEcCtD
Dicyclomine—Nausea—Gemcitabine—kidney cancer	0.000146	0.000453	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000145	0.000452	CcSEcCtD
Dicyclomine—Fatigue—Capecitabine—kidney cancer	0.000145	0.000452	CcSEcCtD
Dicyclomine—Pruritus—Paclitaxel—kidney cancer	0.000145	0.000452	CcSEcCtD
Dicyclomine—Constipation—Capecitabine—kidney cancer	0.000144	0.000448	CcSEcCtD
Dicyclomine—Pain—Capecitabine—kidney cancer	0.000144	0.000448	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—kidney cancer	0.000143	0.000444	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—kidney cancer	0.000142	0.000441	CcSEcCtD
Dicyclomine—Feeling abnormal—Capecitabine—kidney cancer	0.000139	0.000432	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—kidney cancer	0.000138	0.000429	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000138	0.000429	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000138	0.000428	CcSEcCtD
Dicyclomine—Dizziness—Paclitaxel—kidney cancer	0.000136	0.000422	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—kidney cancer	0.000134	0.000417	CcSEcCtD
Dicyclomine—Urticaria—Capecitabine—kidney cancer	0.000134	0.000416	CcSEcCtD
Dicyclomine—Abdominal pain—Capecitabine—kidney cancer	0.000133	0.000414	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—kidney cancer	0.000133	0.000414	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—kidney cancer	0.000131	0.000406	CcSEcCtD
Dicyclomine—Vomiting—Paclitaxel—kidney cancer	0.00013	0.000406	CcSEcCtD
Dicyclomine—Rash—Paclitaxel—kidney cancer	0.000129	0.000403	CcSEcCtD
Dicyclomine—Dermatitis—Paclitaxel—kidney cancer	0.000129	0.000402	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—kidney cancer	0.000129	0.000402	CcSEcCtD
Dicyclomine—Headache—Paclitaxel—kidney cancer	0.000129	0.0004	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—kidney cancer	0.000125	0.00039	CcSEcCtD
Dicyclomine—Hypersensitivity—Capecitabine—kidney cancer	0.000124	0.000386	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000123	0.000384	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—kidney cancer	0.000122	0.00038	CcSEcCtD
Dicyclomine—Nausea—Paclitaxel—kidney cancer	0.000122	0.000379	CcSEcCtD
Dicyclomine—Asthenia—Capecitabine—kidney cancer	0.000121	0.000376	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—kidney cancer	0.00012	0.000373	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—kidney cancer	0.000119	0.000371	CcSEcCtD
Dicyclomine—Pruritus—Capecitabine—kidney cancer	0.000119	0.000371	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—kidney cancer	0.000118	0.000366	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—kidney cancer	0.000117	0.000364	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—kidney cancer	0.000115	0.000357	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—kidney cancer	0.000112	0.000348	CcSEcCtD
Dicyclomine—Dizziness—Capecitabine—kidney cancer	0.000111	0.000347	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—kidney cancer	0.000111	0.000345	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—kidney cancer	0.000109	0.000341	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—kidney cancer	0.000109	0.000338	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000109	0.000338	CcSEcCtD
Dicyclomine—Vomiting—Capecitabine—kidney cancer	0.000107	0.000333	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—kidney cancer	0.000107	0.000332	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—kidney cancer	0.000106	0.000331	CcSEcCtD
Dicyclomine—Rash—Capecitabine—kidney cancer	0.000106	0.00033	CcSEcCtD
Dicyclomine—Dermatitis—Capecitabine—kidney cancer	0.000106	0.00033	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—kidney cancer	0.000106	0.00033	CcSEcCtD
Dicyclomine—Headache—Capecitabine—kidney cancer	0.000105	0.000328	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—kidney cancer	0.000103	0.000322	CcSEcCtD
Dicyclomine—Nausea—Capecitabine—kidney cancer	0.0001	0.000311	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—kidney cancer	9.82e-05	0.000306	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—kidney cancer	9.75e-05	0.000303	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—kidney cancer	9.68e-05	0.000301	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—kidney cancer	9.65e-05	0.0003	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—kidney cancer	9.56e-05	0.000297	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—kidney cancer	9.44e-05	0.000294	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.37e-05	0.000292	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—kidney cancer	9.36e-05	0.000291	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—kidney cancer	9.28e-05	0.000289	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—kidney cancer	9.28e-05	0.000289	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—kidney cancer	8.95e-05	0.000278	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—kidney cancer	8.88e-05	0.000276	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—kidney cancer	8.62e-05	0.000268	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—kidney cancer	8.58e-05	0.000267	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—kidney cancer	8e-05	0.000249	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—kidney cancer	7.79e-05	0.000242	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—kidney cancer	7.68e-05	0.000239	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—kidney cancer	7.18e-05	0.000223	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—kidney cancer	6.9e-05	0.000215	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—kidney cancer	6.84e-05	0.000213	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—kidney cancer	6.84e-05	0.000213	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—kidney cancer	6.8e-05	0.000212	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—kidney cancer	6.45e-05	0.000201	CcSEcCtD
